157 related articles for article (PubMed ID: 36855845)
1. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I
J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
[No Abstract] [Full Text] [Related]
2. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.
Kim M; Li M; Intong LR; Tran K; Melbourne W; Marucci D; Bucci J; de Souza P; Mallesara G; Murrell DF
Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414
[No Abstract] [Full Text] [Related]
3. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Reimer A; Lu S; He Y; Bruckner-Tuderman L; Technau-Hafsi K; Meiss F; Has C; von Bubnoff D
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134
[No Abstract] [Full Text] [Related]
4. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
5. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
Ciurescu D; Condruz S; Irimie M
Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
7. Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.
Medek K; Koelblinger P; Koller J; Diem A; Ude-Schoder K; Bauer JW; Laimer M
J Dtsch Dermatol Ges; 2019 Apr; 17(4):448-450. PubMed ID: 30821421
[No Abstract] [Full Text] [Related]
8. Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.
Piccerillo A; El Hachem M; De Vito R; De Luca EV; Peris K
JAMA Dermatol; 2020 Jun; 156(6):708-710. PubMed ID: 32320041
[No Abstract] [Full Text] [Related]
9. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
Fourel E; Claudy AL
Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
[TBL] [Abstract][Full Text] [Related]
10. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S
Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
12. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
13. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
14. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
Jacków J; Rami A; Hayashi R; Hansen C; Guo Z; DeLorenzo D; Pappalardo A; Alvarez Cespedes D; Kim AL; Perez-Lorenzo R; Owens DM; Christiano AM
J Invest Dermatol; 2021 Apr; 141(4):942-946. PubMed ID: 33069729
[No Abstract] [Full Text] [Related]
16. Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient.
Xará J; Relvas M; Figueiredo C; Calvão J; Batista M; Ramos L
Int J Dermatol; 2023 Dec; 62(12):e617-e618. PubMed ID: 37622659
[No Abstract] [Full Text] [Related]
17. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.
Tomita Y; Sato-Matsumura KC; Sawamura D; Matsumura T; Shimizu H
Acta Derm Venereol; 2003; 83(3):225-6. PubMed ID: 12816163
[No Abstract] [Full Text] [Related]
18. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Rodeck U; Fertala A; Uitto J
Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]